0
     

Report Added
Report already added
Active Implantable Devices Market - Global Outlook and Forecast 2022-2028

Active Implantable Devices Market - Global Outlook and Forecast 2022-2028

Active implantable medical devices are powered devices that are inserted into a patient’s body, through either a natural orifice or by surgical means, and are intended to remain in the patient’s body after the procedure. Such devices are usually battery powered, and the power supply can either be contained in the instrument or be connected to wires that protrude from the patient’s body.
This report contains market size and forecasts of Active Implantable Devices in global, including the following market information:

Global Active Implantable Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Implantable Devices Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Active Implantable Devices companies in 2021 (%)
The global Active Implantable Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Cardioverter Defibrillator Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Implantable Devices include LivaNova PLC(U.K.), MED-EL(Austria), Medtronic(Ireland), Abbott Laboratories(U.S.), BIOTRONIK(Germany), Boston Scientific Corporation(U.S.), Cochlear Limited(Australia), Nurotron Biotechnology(China) and Sonova Holding Switzerland) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Implantable Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Active Implantable Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Active Implantable Devices Market Segment Percentages, by Type, 2021 (%)
Implantable Cardioverter Defibrillator
Implantable Cardiac Pacemakers
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Neurostimulators
Implantable Hearing Devices
Global Active Implantable Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Active Implantable Devices Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Active Implantable Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Active Implantable Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Implantable Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Implantable Devices revenues share in global market, 2021 (%)
Key companies Active Implantable Devices sales in global market, 2017-2022 (Estimated), (Units)
Key companies Active Implantable Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
LivaNova PLC(U.K.)
MED-EL(Austria)
Medtronic(Ireland)
Abbott Laboratories(U.S.)
BIOTRONIK(Germany)
Boston Scientific Corporation(U.S.)
Cochlear Limited(Australia)
Nurotron Biotechnology(China)
Sonova Holding Switzerland)
William Demant Holding(Denmark)
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Active Implantable Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Implantable Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Implantable Devices Overall Market Size
2.1 Global Active Implantable Devices Market Size: 2021 VS 2028
2.2 Global Active Implantable Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Active Implantable Devices Sales: 2017-2028
3 Company Landscape
3.1 Top Active Implantable Devices Players in Global Market
3.2 Top Global Active Implantable Devices Companies Ranked by Revenue
3.3 Global Active Implantable Devices Revenue by Companies
3.4 Global Active Implantable Devices Sales by Companies
3.5 Global Active Implantable Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Active Implantable Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Active Implantable Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Implantable Devices Players in Global Market
3.8.1 List of Global Tier 1 Active Implantable Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Implantable Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Active Implantable Devices Market Size Markets, 2021 & 2028
4.1.2 Implantable Cardioverter Defibrillator
4.1.3 Implantable Cardiac Pacemakers
4.1.4 Ventricular Assist Devices
4.1.5 Implantable Heart Monitors/Insertable Loop Recorders
4.1.6 Neurostimulators
4.1.7 Implantable Hearing Devices
4.2 By Type - Global Active Implantable Devices Revenue & Forecasts
4.2.1 By Type - Global Active Implantable Devices Revenue, 2017-2022
4.2.2 By Type - Global Active Implantable Devices Revenue, 2023-2028
4.2.3 By Type - Global Active Implantable Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Active Implantable Devices Sales & Forecasts
4.3.1 By Type - Global Active Implantable Devices Sales, 2017-2022
4.3.2 By Type - Global Active Implantable Devices Sales, 2023-2028
4.3.3 By Type - Global Active Implantable Devices Sales Market Share, 2017-2028
4.4 By Type - Global Active Implantable Devices Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Active Implantable Devices Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Active Implantable Devices Revenue & Forecasts
5.2.1 By Application - Global Active Implantable Devices Revenue, 2017-2022
5.2.2 By Application - Global Active Implantable Devices Revenue, 2023-2028
5.2.3 By Application - Global Active Implantable Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Active Implantable Devices Sales & Forecasts
5.3.1 By Application - Global Active Implantable Devices Sales, 2017-2022
5.3.2 By Application - Global Active Implantable Devices Sales, 2023-2028
5.3.3 By Application - Global Active Implantable Devices Sales Market Share, 2017-2028
5.4 By Application - Global Active Implantable Devices Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Active Implantable Devices Market Size, 2021 & 2028
6.2 By Region - Global Active Implantable Devices Revenue & Forecasts
6.2.1 By Region - Global Active Implantable Devices Revenue, 2017-2022
6.2.2 By Region - Global Active Implantable Devices Revenue, 2023-2028
6.2.3 By Region - Global Active Implantable Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Active Implantable Devices Sales & Forecasts
6.3.1 By Region - Global Active Implantable Devices Sales, 2017-2022
6.3.2 By Region - Global Active Implantable Devices Sales, 2023-2028
6.3.3 By Region - Global Active Implantable Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Active Implantable Devices Revenue, 2017-2028
6.4.2 By Country - North America Active Implantable Devices Sales, 2017-2028
6.4.3 US Active Implantable Devices Market Size, 2017-2028
6.4.4 Canada Active Implantable Devices Market Size, 2017-2028
6.4.5 Mexico Active Implantable Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Active Implantable Devices Revenue, 2017-2028
6.5.2 By Country - Europe Active Implantable Devices Sales, 2017-2028
6.5.3 Germany Active Implantable Devices Market Size, 2017-2028
6.5.4 France Active Implantable Devices Market Size, 2017-2028
6.5.5 U.K. Active Implantable Devices Market Size, 2017-2028
6.5.6 Italy Active Implantable Devices Market Size, 2017-2028
6.5.7 Russia Active Implantable Devices Market Size, 2017-2028
6.5.8 Nordic Countries Active Implantable Devices Market Size, 2017-2028
6.5.9 Benelux Active Implantable Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Active Implantable Devices Revenue, 2017-2028
6.6.2 By Region - Asia Active Implantable Devices Sales, 2017-2028
6.6.3 China Active Implantable Devices Market Size, 2017-2028
6.6.4 Japan Active Implantable Devices Market Size, 2017-2028
6.6.5 South Korea Active Implantable Devices Market Size, 2017-2028
6.6.6 Southeast Asia Active Implantable Devices Market Size, 2017-2028
6.6.7 India Active Implantable Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Active Implantable Devices Revenue, 2017-2028
6.7.2 By Country - South America Active Implantable Devices Sales, 2017-2028
6.7.3 Brazil Active Implantable Devices Market Size, 2017-2028
6.7.4 Argentina Active Implantable Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Implantable Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Active Implantable Devices Sales, 2017-2028
6.8.3 Turkey Active Implantable Devices Market Size, 2017-2028
6.8.4 Israel Active Implantable Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Active Implantable Devices Market Size, 2017-2028
6.8.6 UAE Active Implantable Devices Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 LivaNova PLC(U.K.)
7.1.1 LivaNova PLC(U.K.) Corporate Summary
7.1.2 LivaNova PLC(U.K.) Business Overview
7.1.3 LivaNova PLC(U.K.) Active Implantable Devices Major Product Offerings
7.1.4 LivaNova PLC(U.K.) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.1.5 LivaNova PLC(U.K.) Key News
7.2 MED-EL(Austria)
7.2.1 MED-EL(Austria) Corporate Summary
7.2.2 MED-EL(Austria) Business Overview
7.2.3 MED-EL(Austria) Active Implantable Devices Major Product Offerings
7.2.4 MED-EL(Austria) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.2.5 MED-EL(Austria) Key News
7.3 Medtronic(Ireland)
7.3.1 Medtronic(Ireland) Corporate Summary
7.3.2 Medtronic(Ireland) Business Overview
7.3.3 Medtronic(Ireland) Active Implantable Devices Major Product Offerings
7.3.4 Medtronic(Ireland) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.3.5 Medtronic(Ireland) Key News
7.4 Abbott Laboratories(U.S.)
7.4.1 Abbott Laboratories(U.S.) Corporate Summary
7.4.2 Abbott Laboratories(U.S.) Business Overview
7.4.3 Abbott Laboratories(U.S.) Active Implantable Devices Major Product Offerings
7.4.4 Abbott Laboratories(U.S.) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.4.5 Abbott Laboratories(U.S.) Key News
7.5 BIOTRONIK(Germany)
7.5.1 BIOTRONIK(Germany) Corporate Summary
7.5.2 BIOTRONIK(Germany) Business Overview
7.5.3 BIOTRONIK(Germany) Active Implantable Devices Major Product Offerings
7.5.4 BIOTRONIK(Germany) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.5.5 BIOTRONIK(Germany) Key News
7.6 Boston Scientific Corporation(U.S.)
7.6.1 Boston Scientific Corporation(U.S.) Corporate Summary
7.6.2 Boston Scientific Corporation(U.S.) Business Overview
7.6.3 Boston Scientific Corporation(U.S.) Active Implantable Devices Major Product Offerings
7.6.4 Boston Scientific Corporation(U.S.) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.6.5 Boston Scientific Corporation(U.S.) Key News
7.7 Cochlear Limited(Australia)
7.7.1 Cochlear Limited(Australia) Corporate Summary
7.7.2 Cochlear Limited(Australia) Business Overview
7.7.3 Cochlear Limited(Australia) Active Implantable Devices Major Product Offerings
7.7.4 Cochlear Limited(Australia) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.7.5 Cochlear Limited(Australia) Key News
7.8 Nurotron Biotechnology(China)
7.8.1 Nurotron Biotechnology(China) Corporate Summary
7.8.2 Nurotron Biotechnology(China) Business Overview
7.8.3 Nurotron Biotechnology(China) Active Implantable Devices Major Product Offerings
7.8.4 Nurotron Biotechnology(China) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.8.5 Nurotron Biotechnology(China) Key News
7.9 Sonova Holding Switzerland)
7.9.1 Sonova Holding Switzerland) Corporate Summary
7.9.2 Sonova Holding Switzerland) Business Overview
7.9.3 Sonova Holding Switzerland) Active Implantable Devices Major Product Offerings
7.9.4 Sonova Holding Switzerland) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.9.5 Sonova Holding Switzerland) Key News
7.10 William Demant Holding(Denmark)
7.10.1 William Demant Holding(Denmark) Corporate Summary
7.10.2 William Demant Holding(Denmark) Business Overview
7.10.3 William Demant Holding(Denmark) Active Implantable Devices Major Product Offerings
7.10.4 William Demant Holding(Denmark) Active Implantable Devices Sales and Revenue in Global (2017-2022)
7.10.5 William Demant Holding(Denmark) Key News
8 Global Active Implantable Devices Production Capacity, Analysis
8.1 Global Active Implantable Devices Production Capacity, 2017-2028
8.2 Active Implantable Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Implantable Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Active Implantable Devices Supply Chain Analysis
10.1 Active Implantable Devices Industry Value Chain
10.2 Active Implantable Devices Upstream Market
10.3 Active Implantable Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Implantable Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Active Implantable Devices in Global Market
Table 2. Top Active Implantable Devices Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Active Implantable Devices Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Active Implantable Devices Revenue Share by Companies, 2017-2022
Table 5. Global Active Implantable Devices Sales by Companies, (Units), 2017-2022
Table 6. Global Active Implantable Devices Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Active Implantable Devices Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Active Implantable Devices Product Type
Table 9. List of Global Tier 1 Active Implantable Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Implantable Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Active Implantable Devices Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Active Implantable Devices Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Active Implantable Devices Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Active Implantable Devices Sales (Units), 2017-2022
Table 15. By Type - Global Active Implantable Devices Sales (Units), 2023-2028
Table 16. By Application – Global Active Implantable Devices Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Active Implantable Devices Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Active Implantable Devices Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Active Implantable Devices Sales (Units), 2017-2022
Table 20. By Application - Global Active Implantable Devices Sales (Units), 2023-2028
Table 21. By Region – Global Active Implantable Devices Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Active Implantable Devices Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Active Implantable Devices Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Active Implantable Devices Sales (Units), 2017-2022
Table 25. By Region - Global Active Implantable Devices Sales (Units), 2023-2028
Table 26. By Country - North America Active Implantable Devices Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Active Implantable Devices Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Active Implantable Devices Sales, (Units), 2017-2022
Table 29. By Country - North America Active Implantable Devices Sales, (Units), 2023-2028
Table 30. By Country - Europe Active Implantable Devices Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Active Implantable Devices Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Active Implantable Devices Sales, (Units), 2017-2022
Table 33. By Country - Europe Active Implantable Devices Sales, (Units), 2023-2028
Table 34. By Region - Asia Active Implantable Devices Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Active Implantable Devices Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Active Implantable Devices Sales, (Units), 2017-2022
Table 37. By Region - Asia Active Implantable Devices Sales, (Units), 2023-2028
Table 38. By Country - South America Active Implantable Devices Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Active Implantable Devices Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Active Implantable Devices Sales, (Units), 2017-2022
Table 41. By Country - South America Active Implantable Devices Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Active Implantable Devices Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Active Implantable Devices Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Active Implantable Devices Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Active Implantable Devices Sales, (Units), 2023-2028
Table 46. LivaNova PLC(U.K.) Corporate Summary
Table 47. LivaNova PLC(U.K.) Active Implantable Devices Product Offerings
Table 48. LivaNova PLC(U.K.) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. MED-EL(Austria) Corporate Summary
Table 50. MED-EL(Austria) Active Implantable Devices Product Offerings
Table 51. MED-EL(Austria) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Medtronic(Ireland) Corporate Summary
Table 53. Medtronic(Ireland) Active Implantable Devices Product Offerings
Table 54. Medtronic(Ireland) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Abbott Laboratories(U.S.) Corporate Summary
Table 56. Abbott Laboratories(U.S.) Active Implantable Devices Product Offerings
Table 57. Abbott Laboratories(U.S.) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. BIOTRONIK(Germany) Corporate Summary
Table 59. BIOTRONIK(Germany) Active Implantable Devices Product Offerings
Table 60. BIOTRONIK(Germany) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Boston Scientific Corporation(U.S.) Corporate Summary
Table 62. Boston Scientific Corporation(U.S.) Active Implantable Devices Product Offerings
Table 63. Boston Scientific Corporation(U.S.) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Cochlear Limited(Australia) Corporate Summary
Table 65. Cochlear Limited(Australia) Active Implantable Devices Product Offerings
Table 66. Cochlear Limited(Australia) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Nurotron Biotechnology(China) Corporate Summary
Table 68. Nurotron Biotechnology(China) Active Implantable Devices Product Offerings
Table 69. Nurotron Biotechnology(China) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Sonova Holding Switzerland) Corporate Summary
Table 71. Sonova Holding Switzerland) Active Implantable Devices Product Offerings
Table 72. Sonova Holding Switzerland) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. William Demant Holding(Denmark) Corporate Summary
Table 74. William Demant Holding(Denmark) Active Implantable Devices Product Offerings
Table 75. William Demant Holding(Denmark) Active Implantable Devices Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Active Implantable Devices Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 77. Global Active Implantable Devices Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Active Implantable Devices Production by Region, 2017-2022 (Units)
Table 79. Global Active Implantable Devices Production by Region, 2023-2028 (Units)
Table 80. Active Implantable Devices Market Opportunities & Trends in Global Market
Table 81. Active Implantable Devices Market Drivers in Global Market
Table 82. Active Implantable Devices Market Restraints in Global Market
Table 83. Active Implantable Devices Raw Materials
Table 84. Active Implantable Devices Raw Materials Suppliers in Global Market
Table 85. Typical Active Implantable Devices Downstream
Table 86. Active Implantable Devices Downstream Clients in Global Market
Table 87. Active Implantable Devices Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Active Implantable Devices Segment by Type
Figure 2. Active Implantable Devices Segment by Application
Figure 3. Global Active Implantable Devices Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Active Implantable Devices Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Active Implantable Devices Revenue, 2017-2028 (US$, Mn)
Figure 7. Active Implantable Devices Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Active Implantable Devices Revenue in 2021
Figure 9. By Type - Global Active Implantable Devices Sales Market Share, 2017-2028
Figure 10. By Type - Global Active Implantable Devices Revenue Market Share, 2017-2028
Figure 11. By Type - Global Active Implantable Devices Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Active Implantable Devices Sales Market Share, 2017-2028
Figure 13. By Application - Global Active Implantable Devices Revenue Market Share, 2017-2028
Figure 14. By Application - Global Active Implantable Devices Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Active Implantable Devices Sales Market Share, 2017-2028
Figure 16. By Region - Global Active Implantable Devices Revenue Market Share, 2017-2028
Figure 17. By Country - North America Active Implantable Devices Revenue Market Share, 2017-2028
Figure 18. By Country - North America Active Implantable Devices Sales Market Share, 2017-2028
Figure 19. US Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Active Implantable Devices Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Active Implantable Devices Sales Market Share, 2017-2028
Figure 24. Germany Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 25. France Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Active Implantable Devices Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Active Implantable Devices Sales Market Share, 2017-2028
Figure 33. China Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 37. India Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Active Implantable Devices Revenue Market Share, 2017-2028
Figure 39. By Country - South America Active Implantable Devices Sales Market Share, 2017-2028
Figure 40. Brazil Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Active Implantable Devices Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Active Implantable Devices Sales Market Share, 2017-2028
Figure 44. Turkey Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Active Implantable Devices Revenue, (US$, Mn), 2017-2028
Figure 48. Global Active Implantable Devices Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Active Implantable Devices by Region, 2021 VS 2028
Figure 50. Active Implantable Devices Industry Value Chain
Figure 51. Marketing Channels

Report Title: Active Implantable Devices Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027